Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Some ethical considerations in clinical trials.

R J Levine, K Lebacqz

    Clinical Pharmacology and Therapeutics
    |May 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    DIAGNOSTIC METHODS FOR SEROTONIN AND HISTAMINE ABNORMALITIES.

    A listing of research in the cardiovascular field·2014
    Same author

    The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia.

    BJOG : an international journal of obstetrics and gynaecology·2010
    Same author

    Crossbridge and backbone structure of invertebrate thick filaments.

    Biophysical journal·2009
    Same author

    Effect of breastfeeding on cognitive development of infants born small for gestational age.

    Acta paediatrica (Oslo, Norway : 1992)·2002
    Same author

    Demystifying central review boards: current options and future directions.

    IRB·2002
    Same author

    A time to die?

    Biomedical ethics (Tubingen, Germany)·2002

    Examining ethical principles, not just regulations, offers a better approach to clinical trial dilemmas. Applying principles to randomized clinical trials (RCTs) addresses justice and disclosure issues for patient well-being.

    Area of Science:

    • Medical Ethics
    • Clinical Trial Design
    • Research Regulations

    Background:

    • Current ethical codes and regulations for clinical trials are often too vague to address specific ethical challenges.
    • Existing regulations struggle to provide clear guidance on complex issues arising in clinical research.
    • There is a need for a more robust framework to navigate ethical dilemmas in clinical trials.

    Purpose of the Study:

    • To propose a more effective approach to resolving ethical problems in clinical trials by examining underlying ethical principles.
    • To apply this principle-based approach to specific ethical questions concerning participant selection and informed consent in randomized clinical trials (RCTs).
    • To enhance clarity on ethical disagreements and guide the establishment of an ethical context for clinical trials.

    Main Methods:

    Keywords:
    Biomedical and Behavioral Research

    Related Experiment Videos

    • Analysis of ethical principles underpinning existing clinical trial norms and regulations.
    • Application of these ethical principles to two case studies: participant selection in Veterans Administration (VA) hospitals and disclosure of randomization.
    • Evaluation of justice and informed consent issues based on ethical principles.

    Main Results:

    • Ethical challenges in RCTs involve not only patient vulnerability but also the alteration of the physician-patient relationship.
    • Using patients from VA hospitals in RCTs can be ethically justifiable with appropriate design modifications to ensure justice.
    • Disclosure of randomization is necessary when it materially impacts a potential participant's decision, considering their values and preferences.

    Conclusions:

    • An ethical principle-based approach provides a more fruitful method for addressing clinical trial ethical issues than solely relying on specific regulations.
    • Justice in clinical trials requires careful consideration of participant vulnerability and the impact on the physician-patient relationship.
    • Transparency regarding randomization is crucial for respecting participant autonomy and ensuring informed consent in clinical trials.